本頁面由Tiger Trade Technology Pte. Ltd.提供服務

Benitec Biopharma Limited

11.04
-0.0100-0.09%
盤後11.040.00000.00%16:10 EDT
成交量:13.88萬
成交額:154.55萬
市值:3.85億
市盈率:-9.97
高:11.45
開:11.09
低:10.89
收:11.05
52周最高:16.76
52周最低:9.85
股本:3,488.27萬
流通股本:1,845.34萬
量比:1.11
換手率:0.75%
股息:- -
股息率:- -
每股收益(TTM):-1.1074
每股收益(LYR):-0.9800
淨資產收益率:-33.21%
總資產收益率:-22.67%
市淨率:2.18
市盈率(LYR):-11.27

資料載入中...

2023/08/11

重要事件披露

Form 8-K - Current report
2023/08/10

重要事件披露

Form 8-K - Current report
2023/08/07

[修訂]招股説明書

Form S-1/A - General form for registration of securities under the Securities Act of 1933: [Amend]
2023/08/03

[修訂]招股説明書

Form S-1/A - General form for registration of securities under the Securities Act of 1933: [Amend]
2023/08/03

SEC問詢函

Form CORRESP - Correspondence
2023/08/03

SEC問詢函

Form CORRESP - Correspondence
2023/07/31

[修訂]招股説明書

Form S-1/A - General form for registration of securities under the Securities Act of 1933: [Amend]
2023/07/26

重要事件披露

Form 8-K - Current report
2023/07/07

招股説明書

Form S-1 - General form for registration of securities under the Securities Act of 1933
2023/06/26

重要事件披露

Form 8-K - Current report
2023/06/15

重要事件披露

Form 8-K - Current report
2023/05/15

重要事件披露

Form 8-K - Current report
2023/05/15

季度報告

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
2023/04/18

超過5%披露

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
2023/03/08

重要事件披露

8-K - Current report
2023/02/14

超過5%披露

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
2023/02/13

超過5%披露

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
2023/02/13

季度報告

10-Q - Quarterly report [Sections 13 or 15(d)]
2023/02/13

重要事件披露

8-K - Current report
2023/02/08

超過5%披露

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals